Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Pre-Psy Session: Guidelines to Practice in the Treatment of Opioid Use Disorder


Guidelines to Practice in the Treatment of Opioid Use Disorder
 

This grant-funded activity will describe best practices for opioid overdose prevention, compare FDA-approved medications for opioid use disorder, and discuss current controversies and ethical issues in opioid use disorder treatment.

 
Presented By:
Richard Bottner, PA-C
Division of Hospital Medicine, Dell Seton Medical Center
Affiliate Faculty
Dell Medical School at The University of Texas at Austin
 
Kirsten Mason, Pharm.D., BCPS
Clinical Pharmacy Manager
Seton Healthcare Family
 
Lucas G. Hill, Pharm.D
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
 
Christopher Moriates, M.D.
Assistant Dean for Healthcare Value
Associate Chair for Quality, Safety, and Value
Associate Professor of Internal Medicine
Dell Medical School at The University of Texas at Austin
 
 
Nicholas Yagoda, M.D.
Director of Primary Care
CommUnityCare Federally Qualified Health Centers
 

Registration fees are waived for all participants, thanks to a grant from Texas Health and Human Services

 
 

Date: Oct 16, 2019 02:00 PM - 05:15 PM

Fee

$0.00

CE Hours

3.00

CE Units

0.300

Registration closes on Oct 16, 2019 07:00 PM

Activity Type

  • Application

Target Audience(s)

  • Pharmacists
  • Physicians
  • Psychiatrists
  • Psychologists
  • Social Workers

 

 

 

   

Objectives

  • Summarize the pathophysiology of opioid use disorder, pharmacology of buprenorphine, and the process for obtaining an x-waiver license.
  • Evaluate the clinical and business case for building an inpatient buprenorphine program with community partners, and assemble a team of stakeholders.
  • Compose buprenorphine induction algorithms and policies specific to the participant’s institution.
  • Demonstrate appropriate patient-centered language internally and at the bedside to reduce stigma around opioid use disorders.
  • Discuss the multiple dimensions of treating opioid addiction and the need for interprofessional and multidisciplinary team-based care.
  • Apply principles of the Addiction Recovery Medical Home model to OUD and buprenorphine therapy.
Date: 10/16/19
Time: 02:00 PM - 05:15 PM

CE Hours

3.00